ING Group’s Core Laboratories CLB Stock Holding History

ING Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,748	Closed	-$353K	–	534
2019 Q2	$353K	Buy	6,748 +7	+0.1%	+$411	0.01%	616
2019 Q1	$465K	Buy	6,741 +14	+0.2%	+$939	0.01%	469
2018 Q4	$401K	Buy	6,727 +18	+0.3%	+$1.55K	0.01%	512
2018 Q3	$777K	Buy	6,709 +3	+0%	+$338	0.01%	415
2018 Q2	$846K	Buy	+6,706	New	+$816K	0.02%	355

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ING Group's CLB Position: Q3 2019 in Review

ING Group sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 6,748 shares — an estimated $353K sold.

ING Group first reported a position in CLB in Q2 2018 and held it in 5 quarters. The position peaked at $846K in Q2 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

ING Group reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
ING Group sold 6,748 Core Laboratories shares in Q3 2019, an estimated $353K.
ING Group first reported a position in Core Laboratories in Q2 2018 and held it in 5 quarters.
ING Group's Core Laboratories position peaked at $846K in Q2 2018.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.